Rockwell Medical (NASDAQ:RMTI) Releases Earnings Results, Misses Expectations By $0.01 EPS

Rockwell Medical (NASDAQ:RMTI) issued its quarterly earnings results on Monday. The company reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.01), Zacks reports. Rockwell Medical had a negative net margin of 1.25% and a positive return on equity of 8.55%.

Rockwell Medical Trading Down 4.7%

Shares of RMTI stock opened at $1.12 on Monday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.00 and a current ratio of 2.41. Rockwell Medical has a 52-week low of $0.86 and a 52-week high of $5.15. The company has a market capitalization of $38.11 million, a PE ratio of -22.30 and a beta of 1.64. The business’s fifty day moving average is $1.23 and its 200 day moving average is $1.95.

Insider Buying and Selling

In other news, major shareholder Larson Family Inve Irrevocable purchased 57,000 shares of the stock in a transaction on Thursday, April 10th. The shares were acquired at an average price of $1.07 per share, for a total transaction of $60,990.00. Following the completion of the transaction, the insider now directly owns 3,527,000 shares of the company’s stock, valued at approximately $3,773,890. This trade represents a 1.64% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Over the last quarter, insiders have sold 10,680 shares of company stock worth $11,552. Corporate insiders own 3.60% of the company’s stock.

Analysts Set New Price Targets

Separately, HC Wainwright reduced their price objective on Rockwell Medical from $7.00 to $3.00 and set a “buy” rating for the company in a report on Monday, March 24th.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.